Introduction
============

Meta-analysis of mortality after subarachnoid hemorrhage (SAH) found 11.8% rates in Japan, lower than other countries.^[@B1]^ More recent meta-analysis of complications, case-fatality, and risk factors of unruptured cerebral aneurysm (UCA) revealed that the risk was about half in Asia compared with other areas after endovascular treatment and about one-fifth after neurosurgical treatment.^[@B2]^ Genetic characteristics, usual lifestyle, medical environment and resources, and the medical insurance system are different in Japan compared with other countries. Organization for Economic Co-operation and Development (OECD) health data shows that Japan has the most acute care beds per 1000 population, and the highest number of computed tomography (CT), magnetic resonance imaging per million population.^[@B3]^ Additionally, the universal health care system has been totally controlled by the Government in Japan. Japan has more than 1000 neurosurgical facilities for patients with SAH to provide care, and 9688 neurosurgeons and 7685 board-certified neurosurgeons were available in 2017, so earlier diagnosis and more optimal treatment may be available in Japan. Consequently, emergent care for SAH is more easily accessible, and patients with SAH may be taken after earlier in Japan. The present review describes the characteristics and originality of cerebral aneurysm research in Japan.

SAH Incidence Worldwide and Japan
=================================

Finland^[@B4]^ and Japan^[@B5]^ have the highest incidences of SAH worldwide, but recent evidence does not support the abnormally high incidence of SAH in Finland.^[@B6]^ The misconception of such an exceptionally high incidence of SAH in Finland might have originated from reviews including old Finnish studies without the incidence rates standardized to reference populations, such as the European Standard Population.^[@B7]--[@B9]^ The 3-year mean standardized incidence in Finland decreased from 11.7 in 1998--2000 to 8.9 per 100,000 persons in 2010--2012 together with decreasing smoking rates.^[@B10]^ In contrast, the regional incidence rate of SAH in Japan was 15.4^[@B11]^--22.7^[@B8]^ per 100,000, but the nationwide incidence rate and recent trends of incidence of SAH in Japan have never been reported.

Trends in the incidence of SAH worldwide before 2004 indicated either stable^[@B5],[@B12]--[@B15]^ or decreasing rates,^[@B16],[@B17]^ whereas either decrease^[@B10],[@B18]^ or increase^[@B19],[@B20]^ with regional variations was reported after 2005. The recent meta-analysis of worldwide incidence of aneurysmal SAH^[@B21]^ between January 1960 and March 2017 suggested SAH incidence was associated with blood pressure and smoking prevalence. This meta-analysis included 75 studies from 32 countries with 8176 patients with SAH studied over 67,746,051 person-years. Overall crude incidence of SAH across all midyears was 7.9 \[95% confidence interval (CI), 6.9--9.0\] per 100,000 person-years; and the risk ratio (RR) was 1.3 for females (95% CI, 0.98--1.7). Compared with males aged 45--54 years, the RR was 2.5 in Japanese females older than 75 years (1.8--3.4) and 1.5 in European females older than 75 years (0.9--2.5). Clearly, elderly females in Japan have a greatly increased risk of SAH. Global incidence of SAH declined from 10.2 (8.4--12.5) in 1980 to 6.1 (4.9--7.5) per 100,000 person-years in 2010 or by 1.7% (0.6--2.8) annually between 1955 and 2014. Incidences of SAH declined by 46.2% in Asia, 40.6% in Europe, and 14.0% in North America, but increased by 59.1% in Japan between 1980 and 2010. The global incidence of SAH declined by 7.1% (5.8--8.4) per mmHg decrease in systolic blood pressure and by 2.4% (1.6--3.3) per percent decrease in smoking prevalence. Worldwide incidence of SAH and decreases showed great regional differences, parallelly with decreases in blood pressure and smoking prevalence. Therefore, the incidence of SAH could be reduced by identifying the determinants for regional differences and further reducing blood pressure and smoking prevalence. However, all available Japanese data is regional, not nationwide, and extends only up to 2008. [Figure 1](#F1){ref-type="fig"} shows the mortality trend of SAH in Japan from records in a database at the Ministry of Health, Labour, and Welfare,^[@B22]^ indicating the slight decline trend from 2004. However, we must recognize that the crude mortality of SAH could be changed based on the crude incidence of SAH, demographic change, aging change, change of mortality rate, and other related factors during the same period. Therefore, the recent trend in the nationwide incidence of SAH should be evaluated.

Treatment for Aneurysmal SAH
============================

Meta-analysis of patients with aneurysmal SAH reported that endovascular coiling could achieve better clinical out-come than surgical clipping.^[@B23],[@B24]^ The American Heart Association/American Stroke Association guidelines indicated that endovascular coiling should be considered for patients with ruptured aneurysms suitable for both treatments (Class I; Level of Evidence B)^[@B25]^ according to the randomized controlled trial (RCT) of the international subarachnoid aneurysm trial which demonstrated poor outcomes for surgical clipping compared with endovascular coiling.^[@B26]^ However, no reliable clinical RCT is available that can be used directly to guide treatment in patients with poor clinical grading condition after aneurismal SAH.^[@B27]^

Recent meta-analysis found that the outcomes with endovascular coiling was not superior to surgical clipping in patients with high-grade aneurysmal SAH, and that coiling carried greater risk of mortality.^[@B28]^ Analysis of the Japanese Stroke Databank found no significant difference in poor outcome of modified Rankin Scale (mRS) \>2 between surgical clipping and endovascular coiling even at discharge.^[@B29]^ A Japanese nationwide study in 2012 reported that surgical clipping was associated with lower in-hospital mortality compared with endovascular coiling.^[@B30]^ Therefore, the indications for the treatment method tend to depend on the protocol in each institute. The ruptured aneurysm wall might be more fragile due to genetic factors in Japanese compared with western people, because UCA was 2.8 times more likely to rupture in Japanese than in western population,^[@B31]^ and Asian people was a significant risk factor for rupture during the procedure of endovascular coiling (*P* \<0.0001).^[@B32]^

The outcome at discharge measured by mRS was evaluated by use of the comprehensive national database in Japan.^[@B33]^ In this database registered between 2010 and 2015, propensity score-matched analysis was conducted for aneurysmal SAH. Poor outcome of mRS \>2 showed no significant difference between endovascular coiling and surgical clipping (48.3% vs 47.7%, *P* = 0.48). However, significantly lower in-hospital mortality after surgical clipping was observed compared with endovascular coiling (7.1% vs 12.2%, *P* \<0.001). This study conducted additional meta-analysis of studies using the nationwide databases comparing between surgical clipping and endovascular coiling published from 2007 to 2018. No significant association was found for poor outcome at discharge between endovascular coiling and surgical clipping \[odds ratio (OR), 1.08; 95% CI, 0.93--1.26; *P* = 0.31\] ([Fig. 2](#F2){ref-type="fig"}). Lower in-hospital mortality was found after surgical clipping than after endovascular coiling, but without significant difference (0.74; 0.52--1.04; *P* = 0.08) ([Fig. 3](#F3){ref-type="fig"}). This meta-analysis was mainly based on the data from nationwide databases in Japan. The reason for no significant difference in poor outcomes might be due to the lower chance for positive life-saving treatment and higher indication for withdrawal in elderly patients, because endovascular coiling is easy to select for the elderly, and Japan has highest aging population in the world.

These data could tell us the different result of outcome for aneurysmal SAH in Japan from other countries. Therefore, possible speculations for this reason should be considered. The OECD data showed that Japan had the most acute care beds per 1000 population and the largest number of CT and magnetic resonance imaging (MRI) units per million population.^[@B3]^ Consequently, neurosurgical facilities, neurosurgeons, and board-certified neurosurgeons can establish the diagnosis more rapidly and immediately treat all patients under universal health care system.

Small UCA
=========

Asymptomatic UCAs are frequently discovered at screening check-ups in Japan.^[@B34]^ Most such UCAs are small with diameter under 5 mm.^[@B35],[@B36]^ On the other hand, reported rates of small ruptured cerebral aneurysms of ≤5 mm and \<5 mm were over 45%^[@B37],[@B38]^ and 35%,^[@B39]^ respectively. The reason for this discrepancy may be that most acute SAH originates from recently formed aneurysms, so called the small unruptured aneurysm verification (SUAVe) Study type I aneurysm.^[@B40],[@B41]^ Namely, this type I of UCA will rupture immediately after forming and may be difficult to follow clinically and radiologically from formation to rupture. However, this hypothesis remains unproven. Therefore, more knowledge is needed about the natural history and management for small UCAs, although size is one of the risk factors for rupture.^[@B35]^

Two prospective cohort studies have investigated small UCA in Japan^[@B40]^ and Germany.^[@B42]^ The criteria for small UCA were 5 mm in Japan and 7 mm in Germany, but the final annual rupture rates were 2.7 times higher in Japan at 0.54% per year compared with Germany at 0.2% per year, similar to the findings of the PHASES study.^[@B31]^ Interestingly, the risk factors were similar in both studies, which identified age \<50 years and hypertension. Moreover, age \<50 years was another risk factor with special reference to small UCAs,^[@B40],[@B42],[@B43]^ despite age over 70 years old as the reported risk factor for rupture for all UCAs.^[@B31],[@B44]^ The risk of aneurysm rupture is higher in the Japanese population than in other populations, despite the similar prevalence of UCA in these populations.^[@B45]^ Therefore, genetic differences might be an explanation for the higher rupture rates in the SUAVe Study and in the UCA Study of Japan (UCAS Japan). However, the incidence of SAH in China is not high, indicating that any genetic influence may not be so important.^[@B46]^

Recently, we investigated the rupture risk for small UCA using the data of UCAS Japan.^[@B47]^ During registration, 2839 patients (49.6%) had 3132 (46.8%) small UCAs of 3--4 mm in diameter. We investigated the registered, treated, and rupture numbers of these small UCAs and the annual rupture rate, and compared the characteristics of patients and aneurysms to those of larger unruptured aneurysms (≥5 mm) to identify the risk factors using univariate and multivariate analyses. Treatment of small UCAs was performed in 1132 (37.1% of all treated aneurysms) patients and rupture occurred in 23 (20.7% of all ruptured aneurysms) patients ([Fig. 4](#F4){ref-type="fig"}). If all small UCAs \<5 mm were followed up without interventional treatment, the proportion of small ruptured UCA was estimated at 32.4% of all ruptured aneurysms. Therefore, the annual rupture rate of small aneurysms is low, but the actual number of ruptures is not low. Consequently, small aneurysms that rupture during the follow-up period could be detected, screened, and managed based on the individual risk factors. Additionally, multivariate risk-factor analysis revealed that brain check-up screening \[hazard ratio (HR), 4.1; 95% CI, 1.2--14.4\], history of SAH (10.8; 2.3--51.1), uncontrolled hypertension (5.2; 1.8--15.3), and location on the anterior communicating artery (5.0; 1.6--15.5) were independent predictors of rupture. However, the log-rank test found no significant association with brain check-up screening (*P* = 0.16) ([Fig. 5](#F5){ref-type="fig"}). Possible selection criteria for treatment of patients with small UCAs include history of SAH, uncontrolled hypertension, location on the anterior communicating artery, and young age.

Treatment for UCA
=================

The American Heart Association and the American Stroke Association updated the guidelines for managing patients with UCAs in 2015,^[@B48]^ indicating that the treatment risk for patients with UCAs is related to advancing age, medical comorbidities, and aneurysm location and size, so observation is a reasonable alternative in older patients (\>65 years of age) and patients with small asymptomatic UCAs associated with medical comorbidities and low hemorrhage risk based on location, size, morphology, family history, and other relevant factors (Class IIa; Level of Evidence B). Therefore, the treatment indications for UCA in the elderly remain unclear. Clearly, some elderly patients are indicated for interventional treatment based on the individual rupture risk, as the aged population increases worldwide. In fact, both surgical clipping and endovascular coiling were performed for UCA in increasing numbers of elderly per 100,000 Medicare beneficiaries from 2000 to 2010.^[@B20]^ Higher age is a significant risk factor for UCA rupture in elderly patients.^[@B49]^ The Japanese population includes a very high proportion of elderly individuals and Japan has the highest life expectancy at birth worldwide, according to health data from the OECD.^[@B50]^ Therefore, many elderly patients aged over 65 years old receive treatment for UCAs in Japan. Such aging of the population is expected to occur in other countries in the near future. Consequently, the outcome and risk factors for morbidity in elderly patients with UCAs should be investigated.

The recent meta-analysis^[@B2]^ included 114 studies containing 106,433 patients with 108,263 UCAs. Endovascular treatment (74 studies) showed a pooled clinical complication risk of 4.96% (95% CI, 4.00--6.12) and case-fatality rate of 0.30% (0.20--0.40). Risk factors associated with complications were female (pooled OR, 1.06; 95% CI, 1.01--1.11), cardiac comorbidity (2.27; 1.53--3.37), diabetes mellitus (OR, 1.81; 95% CI, 1.05--3.13), hyperlipidemia (1.76; 1.3--2.37), wide aneurysm neck (\>4 mm or dome-to-neck ratio \>1.5) (1.71; 1.38--2.11), posterior circulation aneurysm (1.42; 1.15--1.74), stenting (3.43; 1.45--8.09) and stent-assisted coiling (1.82; 1.16--2.85). Neurosurgical treatment (54 studies) showed a pooled complication risk of 8.34% (6.25--11.10) and case-fatality rate of 0.10% (0--0.20). Risk factors associated with complications were age (OR per year increase, 1.02; 95% CI, 1.01--1.02), female (0.43; 0.32--0.85), anticoagulation agents (6.36; 2.55--15.85), coagulopathy (2.14; 1.13--4.06), congestive heart failure (2.71; 1.57--4.69), diabetes mellitus (2.38; 1.54--3.67), smoking (1.95; 1.36--2.79), hypertension (1.45; 1.03--2.03), posterior aneurysm location (7.25; 3.70--14.20), and aneurysm calcification (2.89; 1.35--6.18).

The present study found 51% of endovascular treatments and 54% of neurosurgical treatments were from Asia, almost all from Japan, Korea, and China. The pooled crude risk of procedural clinical complications in regions found the risk for endovascular treatment in Asia was 3.31 (95% CI, 2.46--4.44), about half that of other areas, and 3.34 (2.88--6.50) for neurosurgical treatment, about one fifth that of other areas. Therefore, such procedures are very safe in Asia, especially neurosurgical treatment, compared with other areas.

Conclusion
==========

Cerebral aneurysm characteristics and environmental factors in Japan have unique features not found in other countries. Identification of these features is important for the understanding of cerebral aneurysms and SAH worldwide. International joint randomized controlled trials or real-world connected big database study with artificial intelligence may be necessary for further research.
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